IN BRIEF: International Biotechnology notes Pfizer buys investee

International Biotechnology Trust PLC - London-based investment trust managed by SV Health ...

Alliance News 10 May, 2022 | 3:27PM
Email Form Facebook Twitter LinkedIn RSS

International Biotechnology Trust PLC - London-based investment trust managed by SV Health Managers LLP - Notes it has stake in Biohaven Pharmaceutical Holding Co Ltd, a pharmaceutical firm which Pfizer Inc has agreed to acquire for USD11.6 billion. Biohaven is International Biotechnology's seventh-largest holding, representing 4.1% of its net asset value as of March 31. International Biotechnology co-manager Ailsa Craig says deal represents sign "Covid cash" is being put to use on M&A in pharmaceutical sector. The trust notes Biohaven is not a constituent of its benchmark Nasdaq Biotech Index. Biohaven is listed on the New York Stock Exchange.

Current stock price: 588.00 pence, up 2.3% on Tuesday in London

12-month change: down 15%

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
International Biotechnology Ord 625.00 GBX -1.26
Pfizer Inc 53.91 USD -0.15

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.